|
⚲
|
| Keyboard |
| Stelmakh Edward
✚
|
|
|---|---|
| CIK # | 0001887046 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001887046] | |
| 4 | [0001887046] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| OptimizeRx Corp | |
| Stelmakh Edward |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
OptimizeRx Corp OPRX
Common Stock
|
2025-12-23 | Tax withheld | 3,658 | $12.74 | 46,603 |
|
OptimizeRx Corp OPRX
Common Stock
|
2025-12-19 | Sell | 1,388 | $13.51 | 18,752 |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2025-12-19 | Option exercise | 5,237 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2025-12-19 | Option exercise | 5,237 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2025-10-03 | Option exercise | 16,623 | $0.00 | |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2025-10-03 | Option exercise | 16,623 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2025-10-03 | Tax withheld | 4,406 | $18.75 | 82,612 |
|
OptimizeRx Corp OPRX
Common Stock
|
2025-02-15 | Tax withheld | 2,156 | $6.64 | 14,316 |
|
OptimizeRx Corp OPRX
Stock Option · derivative
|
2024-12-23 | Grant | 77,742 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2024-12-23 | Grant | 41,408 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2024-12-19 | Tax withheld | 1,316 | $4.75 | 6,251 |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2024-12-19 | Option exercise | 5,237 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2024-12-19 | Option exercise | 5,237 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2024-10-11 | Tax withheld | 2,066 | $6.63 | 13,698 |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2024-10-11 | Option exercise | 8,222 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2024-10-11 | Option exercise | 8,222 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2024-10-03 | Option exercise | 16,622 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2024-10-03 | Tax withheld | 4,177 | $7.83 | 32,706 |
|
OptimizeRx Corp OPRX
Restricted Stock Units · derivative
|
2024-10-03 | Option exercise | 16,622 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2024-02-15 | Grant | 7,083 | $0.00 | |
| showing 20 of 36 most recent transactions | |||||